Neil R Poulter

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Thomas Unger, Claudio Borghi, Fadi J. Charchar et al. · Hypertension · 2020 · 4.1K citations · Full text

Medicine, Cardiology, Chronic Disease Control +14

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Medicine, Cardiology, Pharmacotherapy +14

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf, Peter Sever, Neil R Poulter et al. · The Lancet · 2005 · 2.9K citations

Medicine, Cardiology, Pharmacology +10

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14